GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

77 hedge funds and large institutions have $19M invested in Galectin Therapeutics in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 8 closing their positions.

Holders
77
Holders Change
-1
Holders Change %
-1.28%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
17
Reduced
21
Closed
8
Calls
$321K
Puts
$208K
Net Calls
+$113K
Net Calls Change
+$525K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$101K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$79K
3
Northern Trust
3
Northern Trust
Illinois
$1.01M
4
Nuveen Asset Management
4
Nuveen Asset Management
Illinois
$255K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$33K

Top Sellers

1
CCB
1
Cutter & Co Brokerage
Missouri
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$109K
3
State of Wisconsin Investment Board
3
State of Wisconsin Investment Board
Wisconsin
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$225K
5
OAM
5
Oxford Asset Management
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
D.E. Shaw & Co
76
D.E. Shaw & Co
New York
– -$55K -19,092 Closed
Squarepoint
77
Squarepoint
New York
– -$42K -14,537 Closed
ARTA
78
A.R.T. Advisors
New York
– -$36K -12,477 Closed
CWA
79
Capital Wealth Alliance
Arizona
– -$4K -1,666 Closed
1 2 3
4